Chapel Hill (Site ID: 3201) — Chapel Hill, North Carolina

Chapel Hill (Site ID: 3201) is a clinical research site located in Chapel Hill, North Carolina, United States 27599.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Chapel Hill (Site ID: 3201) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HIV.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Chapel Hill (Site ID: 3201)?

Chapel Hill (Site ID: 3201) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Chapel Hill (Site ID: 3201) conducted?

Chapel Hill (Site ID: 3201) has 1 clinical trials on record, with 1 currently active. Their work covers HIV.

Is Chapel Hill (Site ID: 3201) accredited by Crixeo Health?

Chapel Hill (Site ID: 3201) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Chapel Hill (Site ID: 3201)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.